GREGORY ROBERTSON: Open Payments
NPI 1932281011 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,546 in 68 payments from 17 companies in 2025. Trend: 2023 $2,615 · 2024 $3,072 · 2025 $1,546
Food & beverage: $1,546
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $360 |
| Amgen Inc. | 16 | $261 |
| Novo Nordisk Inc | 6 | $215 |
| Lilly USA, LLC | 6 | $145 |
| Pharming Healthcare, Inc. | 4 | $82 |
| Exact Sciences Corporation | 3 | $81 |
| Corcept Therapeutics | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| Radius Health, Inc. | 2 | $49 |
| ABBVIE INC. | 1 | $33 |
Products named: EVENITY, AIRSUPRA, Ozempic, FARXIGA, JARDIANCE, MOUNJARO, RUCONEST, Korlym.
Industry payments across CA — which companies pay providers there.
